Allometric scaling of electrical excitation and propagation in the mammalian heart.
Variations in body mass impose constraints on the structure and function of mammalian species, including those of the cardiovascular system. Numerous biological processes, including cardiovascular parameters, have been shown to scale with body mass (BM) according to the law of allometric scaling: Y=Y =a∙BMb(Y, biological process; a, normalization constant; b, scaling exponent, which in many instances is a multiple of ¼). These parameters include heart and breathing rates, intervals and subintervals of the electrocardiogram (ECG), action potential duration (APD), metabolic rate, and temporal properties of ventricular fibrillation. For instance, the hierarchical branching networks of the vascular system, and of the specialized conduction system in the heart have been proposed to be important determinants of allometric scaling. A global and unifying molecular mechanism of allometric scaling has not been put forth, but changes in gene expression have been proposed to play an important role. Even though it is accepted that differences in body size have cardiovascular effects, the use of scaling in the clinical setting is limited. An increase in the clinical utilization of scaling is thought to lead to improved cardiovascular disease diagnosis and management in patients.
Molecular Pharmacology and Physiology. University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States.
Guillaume
G
Bassil
Molecular Pharmacology and Physiology. University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States.
Manuel
M
Zarzoso
Molecular Pharmacology and Physiology. University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States. Electronic address: snoujaim@usf.health.edu.
Sami F
SF
Noujaim
D000818:Animals; D049628:Body Size / Q000502:physiology; D004562:Electrocardiography; D006321:Heart / Q000502:physiology*; D006329:Heart Conduction System / Q000502:physiology*; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D008322:Mammals / Q000502:physiology*; D008955:Models, Cardiovascular; D032383:Myocytes, Cardiac / Q000502:physiology
Circulation. 2008 Apr 29;117(17):2279-87
18443249
Am J Cardiol. 1965 Jul;16:11-21
14314196
J Exp Biol. 2005 May;208(Pt 9):1575-92
15855389
Biol Res. 1997;30(4):167-70
9711327
J Am Coll Cardiol. 1985 Feb;5(2 Pt 1):363-5
3881500
J Gen Physiol. 1999 May;113(5):661-78
10228181
J Theor Biol. 1998 Aug 21;193(4):577-92
9745754
J Am Coll Cardiol. 1992 Aug;20(2):475-9
1634688
J Cardiovasc Electrophysiol. 2002 Aug;13(8):826-30
12212707
Physiol Rev. 1947 Oct;27(4):511-41
20267758
Annu Rev Physiol. 2000;62:25-50
10845083
Heart Rhythm. 2006 Jul;3(7):862-4
16818223
Science. 1997 Apr 4;276(5309):122-6
9082983
Adv Data. 2004 Oct 27;(347):1-17
15544194
J Physiol. 2005 Oct 1;568(Pt 1):255-65
16002448
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20985-9
18093948
Science. 1999 Jun 4;284(5420):1677-9
10356399
J Cardiovasc Electrophysiol. 1999 Feb;10(2):168-73
10090220
Anat Rec. 1995 Jul;242(3):355-73
7573983
Nature. 2010 Apr 1;464(7289):753-6
20360740
Evol Dev. 2009 Sep-Oct;11(5):610-8
19754717
Proc Natl Acad Sci U S A. 2002 Feb 19;99 Suppl 1:2473-8
11875197
Circulation. 2004 Nov 2;110(18):2802-8
15505092
Physiol Genomics. 2008 Nov 12;35(3):262-72
18765860
Ned Tijdschr Geneeskd. 1986 Dec 27;130(52):2344-8
3821962
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4046-9
12637681
Science. 1994 Nov 11;266(5187):1003-6
7973648